Integer Holdings Corporation $ITGR Position Increased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lifted its position in Integer Holdings Corporation (NYSE:ITGR) by 66.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,560 shares of the medical equipment provider’s stock after acquiring an additional 23,800 shares during the period. Assenagon Asset Management S.A. owned about 0.17% of Integer worth $4,671,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC boosted its stake in Integer by 46.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,891 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 912 shares during the period. GAMMA Investing LLC raised its stake in Integer by 166.2% during the 4th quarter. GAMMA Investing LLC now owns 1,134 shares of the medical equipment provider’s stock valued at $89,000 after purchasing an additional 708 shares during the period. Mirabella Financial Services LLP purchased a new stake in shares of Integer in the third quarter valued at $274,000. Tudor Investment Corp ET AL boosted its position in shares of Integer by 50,787.5% in the third quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after buying an additional 29,442,029 shares during the period. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of Integer during the third quarter valued at $380,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Up 0.1%

ITGR opened at $85.45 on Monday. The company has a market capitalization of $2.94 billion, a PE ratio of 29.77, a price-to-earnings-growth ratio of 1.44 and a beta of 0.75. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $127.56. The business has a 50-day moving average of $85.73 and a 200-day moving average of $84.23.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, beating the consensus estimate of $1.70 by $0.06. Integer had a return on equity of 13.26% and a net margin of 5.55%.The business had revenue of $472.06 million during the quarter, compared to analysts’ expectations of $462.73 million. During the same quarter in the previous year, the business posted $1.43 EPS. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Equities research analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Insider Buying and Selling

In other Integer news, VP Tommy P. Thomas sold 825 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president directly owned 4,381 shares of the company’s stock, valued at $372,385. The trade was a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 2.16% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Wells Fargo & Company upped their price target on Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Wall Street Zen cut Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Weiss Ratings upgraded Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Citigroup increased their price target on shares of Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a research report on Friday, February 20th. Finally, Raymond James Financial restated an “outperform” rating and set a $101.00 price target on shares of Integer in a report on Monday, February 23rd. Four analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $102.00.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.